1. Home
  2. CTSO vs ATCX Comparison

CTSO vs ATCX Comparison

Compare CTSO & ATCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.81

Market Cap

45.7M

Sector

Health Care

ML Signal

HOLD

ATCX

Atlas Critical Minerals Corporation Common Stock

N/A

Current Price

$7.12

Market Cap

30.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CTSO
ATCX
Founded
1997
2016
Country
United States
Brazil
Employees
N/A
13
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.7M
30.5M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CTSO
ATCX
Price
$0.81
$7.12
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.38
N/A
AVG Volume (30 Days)
69.2K
70.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$22,503,908.00
N/A
Revenue This Year
$7.29
N/A
Revenue Next Year
$8.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
48.53
N/A
52 Week Low
$0.60
$5.32
52 Week High
$1.39
$14.01

Technical Indicators

Market Signals
Indicator
CTSO
ATCX
Relative Strength Index (RSI) 71.21 50.03
Support Level $0.62 $5.93
Resistance Level $0.85 $14.01
Average True Range (ATR) 0.04 0.79
MACD 0.02 0.15
Stochastic Oscillator 84.73 70.42

Price Performance

Historical Comparison
CTSO
ATCX

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About ATCX Atlas Critical Minerals Corporation Common Stock

Atlas Critical Minerals Corporation, is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel. It also owns mineral rights for iron ore, quartzite, gold, and diamond properties. The company's project portfolio includes the Alto Paranaiba, Malacacheta, Arcos, Goias, Tocantins, Rio Piracicaba, and other projects.

Share on Social Networks: